In parallel to these in vitro results, the improvement of hypertension, vascular remodeling, fibrosis, oxidative stress and inflammation was profoundly reduced in BAIBA-treated SHR when AMPKα1 and SIRT1 in aortas were genetically deleted. Here, PRKAA1 is linked to hypertensive disorder.